27 Nov 2017 07:00
PRESS RELEASE
Â
Â
Ergomed to present at the German Equity Forum 2017
Â
London, UK - 27 November 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a specialised pharmaceutical services and drug development company, today announces its attendance at the German Equity Forum 2017 (Deutsches Eigenkapitalforum) which will be taking place at The Sheraton Frankfurt Airport Hotel & Conference Center in Frankfurt am Main, Germany, from 27 to 29 November.
Â
Dr. Miroslav Reljanovic, Executive Vice-Chairman, will be presenting at 11:00am CET on 27 November.
Â
ENDS
Â
Â
Â
Enquiries:
Â
Ergomed plc | Tel: +44 (0) 1483 503205 | |
Miroslav Reljanovic (Executive Vice Chairman) | ||
Stephen Stamp (Chief Financial Officer) | ||
Numis Securities Limited | Tel: +44 (0) 20 7260 1000 | |
Michael Meade / Freddie Barnfield (Nominated Adviser) | ||
James Black (Joint Broker) | ||
N+1 Singer | Tel: +44 (0) 20 7496 3000 | |
Alex Price (Joint Broker) | ||
Consilium Strategic Communications - for UK enquiries | Tel: +44 (0) 20 3709 5700 | |
Chris Gardner / Mary-Jane Elliott Ivar Milligan / Philippa Gardner | ergomed@consilium-comms.com | |
MC Services - for Continental European enquiries | Tel: +49 211 5292 5222 | |
Anne Hennecke | ||
Â
Â
About Ergomed
Â
Ergomed provides specialist services to the pharmaceutical industry and develops drugs both wholly-owned and through partnerships. Ergomed's fast-growing, profitable service offering spans all phases of clinical development and post-approval pharmacovigilance and medical information. Drawing on more than 20 years of expertise in drug development, Ergomed is also building a growing portfolio of drug development partnerships and programmes, including wholly-owned proprietary products for the treatment of surgical bleeding. For further information, visit: http://ergomedplc.com.
Â